Finvest
KN Electronic Components · Industrial tech · Medtech · Defense · Thesis updated July 19, 2026

PD is pulling Knowles faster

01 Running thesis

A faster PD story

Knowles is turning into a cleaner industrial technology story. The company has shifted toward medtech, defense, industrial, and electrification markets. That mix matters because customers in those markets often need custom parts that are hard to swap out.

The best news is in Precision Devices, or PD. In Q1 2026, PD revenue was $85.1 million, up 17.4% from last year. Its book-to-bill was 1.19, meaning new orders were 19% higher than shipments during the quarter. That points to healthy demand across defense, industrial, electrification, and medtech customers.

The bull case now depends on the specialty film ramp. Management expects that line to help drive 200 to 250 basis points of PD margin expansion in the second half of 2026. A basis point is one one-hundredth of a percentage point, so this would be a margin lift of 2.0 to 2.5 percentage points.

The bear case is about execution and price. If the specialty film ramp slips, the margin lift could slip too. MSA also may cool back toward 2% to 4% growth after a strong Q1. The current score mix also leaves room for debate on valuation, so the stock still needs the better growth and margin story to show up in reported results.

Apr 2026The Q1 2026 filing confirmed a faster setup. Revenue grew 16%, and Knowles disclosed both the new 10% global tariff risk and a possible path to IEEPA tariff refunds.
Apr 2026The Q1 earnings call strengthened the PD case. Management reported a 1.19 PD book-to-bill and raised 2026 organic revenue growth above the prior 4% to 6% target.
Feb 2026The annual filing reinforced Knowles' shift toward medtech, defense, industrial, and electrification markets. It also kept China localization as a live risk for PD.
Feb 2026Management said channel inventory had normalized and orders were matching end-market demand. It also gave a $50 million to $65 million 2026 revenue target for specialty film.
Oct 2025The Q3 2025 filing showed PD revenue up 11.9% year over year and confirmed rising industrial bookings and backlog. It also framed specialty film margin pressure as tied to the ramp.
Oct 2025The Q3 call made PD the clear growth driver. Management said 2026 PD growth could be at or slightly above the high end of its 6% to 8% long-term target.
Jul 2025The Q2 filing confirmed a PD recovery but added concern around MSA margin pressure. MSA EBIT margin fell to 31.2% from 39.4% a year earlier.
Jul 2025The Q2 call showed PD demand was improving, with book-to-bill above 1.15. Management expected sequential and year-over-year growth to continue through the rest of 2025.
02 Business model

Custom parts, premium niches

Knowles makes small, high-value components that go inside other companies' products. Its customers are large device, medical, defense, industrial, and energy companies. Knowles wins when it designs parts that meet tight specs, then produces them at scale.

The company reports two segments. Medtech & Specialty Audio, or MSA, sells parts used in hearing health and specialized audio products, including components for AI-focused medical devices. Precision Devices, or PD, sells high-performance capacitors, RF filters, and specialty film products used in markets like defense, industrial, EV, energy, and downhole fracking.

This model can earn premium margins because the parts are important, technical, and often designed into a customer's product for a long time. It can break if a customer redesigns around a Knowles part, if China buyers shift to local suppliers, or if tariffs raise input costs faster than Knowles can raise prices.

03 Product portfolio

What Knowles sells

Steady

Hearing health components

These parts support hearing aids and related hearing health devices. Q1 2026 shipments benefited from new product introductions, but full-year growth is expected to return closer to the 2% to 4% range.

Option

AI medical device audio parts

Knowles supplies components for AI-optimized medical devices. This gives MSA a path beyond traditional hearing health, but the page view still treats it as an emerging option.

Growth engine

High-performance capacitors

These PD products serve defense, industrial, medtech, and electrification uses. Bookings and backlog in capacitor products had improved for several quarters before the strong Q1 2026 order print.

Steady

RF filtering solutions

RF filters help electronic systems manage signals. In PD, higher factory use in ceramic capacitors and RF microwave products supported margin improvement in 2025.

Growth engine

Specialty film

This is the most important near-term product line. Management has targeted $50 million to $65 million of 2026 revenue from this product category, with energy, downhole fracking, and EV uses.

Cash cow

Syntiant supply agreement products

Knowles still sells some specialty audio products tied to the Syntiant transaction. The risk is that these sales can carry lower margins than the rest of MSA.

04 Business segments

Q1 2026 mix

Precision Devices56%growing fast
Medtech & Specialty Audio44%modest

Segment mix is based on Q1 2026 revenue: PD at $85.1 million and MSA at $68.0 million. PD is the larger segment and the main swing factor for growth and margins.

05 Risk factors

What could go wrong

Specialty film ramp misses

High impact · Medium odds

The bull case expects full volume production of the specialty film energy order by the end of Q2 2026. It also expects that ramp to help lift PD gross margin by 200 to 250 basis points in the second half of 2026. If yields, capacity, or customer timing slip, the margin story weakens fast.

We watchWatch for management updates on specialty film volume production, yields, and second-half 2026 PD gross margin.

MSA growth fades

Medium impact · Medium odds

MSA revenue was $68.0 million in Q1 2026, up 13.9% from last year. Management still expects full-year growth to return toward the 2% to 4% historical range. If that slowdown arrives while PD has any hiccup, total company growth could look less exciting.

We watchWatch MSA revenue growth versus the 2% to 4% range in the next two quarterly reports.

Tariffs raise costs

Medium impact · Medium odds

Knowles disclosed a new temporary 10% global tariff under Section 122 of the Trade Act of 1974. The company is also pursuing potential refunds tied to past IEEPA duties after a court process. The open question is whether new tariff costs outrun any refund benefit.

We watchWatch tariff expense, tariff refund updates, and management comments on pricing actions.

China localization pressure

Medium impact · High odds

Knowles says China's policy of reducing dependence on foreign manufacturers has hurt PD revenue and may keep hurting it. This is not a broad market worry. It is a named pressure point in the segment that now carries the growth story.

We watchWatch PD revenue by end market and any comments on China customer demand or local competitors.

Syntiant exposure disappoints

Medium impact · Medium odds

Knowles has post-divestiture exposure through $77.2 million in Syntiant preferred stock. It also sells some lower-margin specialty audio products to Syntiant under a supply agreement. If Syntiant underperforms, Knowles could face weaker value from the stake or lower-quality MSA sales.

We watchWatch disclosures on the Syntiant preferred stock value and the margin effect of Syntiant-related sales.
06 Quick answers

In one breath

What does Knowles Corporation do?

Knowles makes small electronic components used in hearing devices, medical products, defense systems, industrial equipment, EVs, and energy applications. Its two segments are Medtech & Specialty Audio and Precision Devices.

Why is Precision Devices important to Knowles?

Precision Devices is now the larger segment by Q1 2026 revenue. It is growing faster, with Q1 revenue up 17.4% and a 1.19 book-to-bill, which means orders were higher than shipments.

What is the biggest catalyst for KN stock?

The biggest catalyst is the specialty film energy ramp. Management expects full volume production by the end of Q2 2026 and a 200 to 250 basis point PD margin lift in the second half of 2026.

What is the main risk for Knowles?

The main risk is that the specialty film ramp does not run as planned. Tariffs, China localization, and slower MSA growth are also important risks to track.